Profil
Andy Weymann is currently Chief Executive Officer & Director at Gelmetix Ltd. Dr. Weymann is also a Director at VirtaMed AG since 2021, a Director at Speratum Biopharma, Inc., and a Venture Partner at Verve Capital Partners AG.
Dr. Weymann completed graduate studies at the University of Zurich and holds an MBA from the University of Rochester Simon Business School.
Postes actifs de Andy Weymann
| Sociétés | Poste | Début |
|---|---|---|
VirtaMed AG
VirtaMed AG Personnel ServicesCommercial Services Provides instructional teaching and training of different diagnostic and therapeutic endoscopic interventions | Directeur/Membre du Conseil | 01/06/2021 |
Gelmetix Ltd.
Gelmetix Ltd. Miscellaneous Commercial ServicesCommercial Services Develops non-surgical procedure for the treatment of chronic lower back pain caused by degenerative disc disease | Directeur Général | - |
Speratum Biopharma, Inc.
Speratum Biopharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that focus on research and development of molecular therapeutics | Directeur/Membre du Conseil | - |
Verve Capital Partners AG
Verve Capital Partners AG Investment ManagersFinance Verve Ventures invests in companies located in Europe. The firm focuses on energy & resources, future of computing and health & bio sectors. It provides financing for pre seed, seed and early stage capital requirements with an investment size of EUR 1- 5 million. The firm acts as a lead investor and makes co-investments. | Private Equity Investor | - |
Formation de Andy Weymann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VirtaMed AG
VirtaMed AG Personnel ServicesCommercial Services Provides instructional teaching and training of different diagnostic and therapeutic endoscopic interventions | Commercial Services |
Verve Capital Partners AG
Verve Capital Partners AG Investment ManagersFinance Verve Ventures invests in companies located in Europe. The firm focuses on energy & resources, future of computing and health & bio sectors. It provides financing for pre seed, seed and early stage capital requirements with an investment size of EUR 1- 5 million. The firm acts as a lead investor and makes co-investments. | Finance |
University of Rochester Simon Business School
University of Rochester Simon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gelmetix Ltd.
Gelmetix Ltd. Miscellaneous Commercial ServicesCommercial Services Develops non-surgical procedure for the treatment of chronic lower back pain caused by degenerative disc disease | Commercial Services |
Speratum Biopharma, Inc.
Speratum Biopharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that focus on research and development of molecular therapeutics | Health Technology |
















